Kingdon Capital Management’s enVVeno Medical NVNO Stock Holding History

Kingdon Capital Management’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$387K	Hold	36,166	–	–	0.04%	74
2026 Q1	$366K	Sell	36,166 -1	-0%	-$11	0.04%	67
2025 Q4	$406K	Sell	36,167 -2,669	-7%	-$51.9K	0.05%	68
2025 Q3	$1.23M	Buy	38,836 +14,286	+58%	+$1.46M	0.15%	73
2025 Q2	$3.43M	Hold	24,550	–	–	0.46%	58
2025 Q1	$2.26M	Hold	24,550	–	–	0.24%	60
2024 Q4	$2.59M	Hold	24,550	–	–	0.37%	62
2024 Q3	$2.89M	Buy	24,550 +5,868	+31%	+$1.08M	0.32%	70
2024 Q2	$3.43M	Hold	18,682	–	–	0.37%	70
2024 Q1	$3.56M	Buy	18,682 +991	+6%	+$178K	0.39%	75
2023 Q4	$3.18M	Buy	17,691 +11,429	+183%	+$1.82M	0.4%	64
2023 Q3	$1.18M	Hold	6,262	–	–	0.14%	70
2023 Q2	$675K	Hold	6,262	–	–	0.06%	78
2023 Q1	$1.03M	Hold	6,262	–	–	0.19%	52
2022 Q4	$1.12M	Hold	6,262	–	–	0.22%	46
2022 Q3	$1.38M	Hold	6,262	–	–	0.18%	52
2022 Q2	$829K	Hold	6,262	–	–	0.14%	65
2022 Q1	$1.4M	Hold	6,262	–	–	0.15%	75
2021 Q4	$1.44M	Buy	+6,262	New	+$1.76M	0.17%	71

Other funds holding NVNO

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

Kingdon Capital Management's NVNO Position: Q2 2026 in Review

Kingdon Capital Management held its enVVeno Medical (NVNO) position steady in Q2 2026 at 36,166 shares worth $387K. The position accounts for 0.04% of the portfolio, ranked #74.

Kingdon Capital Management first reported a position in NVNO in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.56M in Q1 2024. 17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

Kingdon Capital Management held 36,166 shares of enVVeno Medical worth $387K as of Q2 2026.
Kingdon Capital Management left its enVVeno Medical share count unchanged in Q2 2026.
enVVeno Medical made up 0.04% of Kingdon Capital Management's portfolio in Q2 2026, its #74 holding.
Kingdon Capital Management first reported a position in enVVeno Medical in Q4 2021 and has held it in 19 quarters since.
Kingdon Capital Management's enVVeno Medical position peaked at $3.56M in Q1 2024.
17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Kingdon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.